11
report
Targeting Tau — Our Hope to Solving the Dementia Crisis
In our systems-based review of the biomedical landscape supporting research of a cellular protein c
alled tau—a common culprit in a number of neurodegenerative diseases—we make the case that focused strategic investment in tau research and the , At present, no disease-modifying therapies for the pure tauopathies exist. Researchers are working to develop effective therapeutic agents, which include approaches such as decreasing the amount of tau within the brain., Symptomatic Interventions
At present, no disease-modifying therapies for the pure tauopathies exist.
+ Read More
report
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners
FasterCures, alongside other patient-focused advocacy organizations, has long worked with stakehold
ers such as product developers and regulators to define and implement the “how to” of patient
+ Read More
report
Misophonia - A Giving Smarter Guide
report
Financing Lung Cancer Screening in China
Lung cancer, one of the most preventable diseases, surpasses all other cancer deaths worldwide.
video
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
October 21 at 11:45 am PDT/2:45 pm EDT
This session will open with a conversation with St
ephen Hahn, Commissioner, US Food and Drug Administration, followed by a panel discussion.
+ Read More
video
Giving Smarter in the Age of COVID-19.
October 20 at 9:00 am PDT/12:00 pm EDT
video
Bridge and Blend: The Role of DFIs in Scaling Sustainable Financing
October 15 at 1:30 pm PDT/4:30 pm EDT
video
Finance as a Force for Good
October 15 at 12:30 pm PDT/3:30 pm EDT
video
Private Markets: Challenges and Opportunities
October 15 at 9:00 am PDT/12:00 pm EDT
video
Measuring Risk and Returns Across ESG Investments.
October 13 at 5:30 am PDT/8:30 am EDT
video
What Is the Prognosis for COVID-19 Treatments and Vaccines?
October 12 at 7:45 am PDT/10:45 am EDT